Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukemia with normal karyotype. (2016). Radiology and Oncology, 50(4). https://www.radioloncol.com/index.php/ro/article/view/2580